A newly identified RNA target could make EGFR drugs work better against glioblastoma

Scientists have discovered that increased expression of a novel long non-coding RNA drives glioblastoma cell growth alongside ...
Healio

Glomerular hyperfiltration may increase CVD risk for patients with type 2 diabetes

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Results showed highest risks for CVD for low eGFR and ...
EurekAlert!

Unmasking a hidden driver of glioma: CHKA teams up with EGFR to ignite the MAPK pathway

Glioma remains one of the deadliest brain cancers, characterized by aggressive growth and limited treatment options. In a new study, researchers from Ningxia Medical University uncovered that choline ...
Hospital Healthcare Europe

EGFR-linked immune pathway amplifying allergic inflammation in asthma identified

A hormone-related interleukin (IL)–epidermal growth factor receptor (EGFR) axis that underpins greater type 2 (T2) ...
Healio

SGLT2 inhibitors may slow eGFR decline in autosomal dominant polycystic kidney disease

Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitors vs. other agents were tied to a slower eGFR decline for adults with ADPKD and type 2 diabetes.